COYA CIK: 1835022

Coya Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.87
FY22:
−9.81
FY23:
−7.90
FY24:
−17.2
FY25:
−22.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.85
FY22:
−7.29
FY23:
−7.88
FY24:
−17.2
FY25:
−22.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.89
FY22:
−12.2
FY23:
−7.26
FY24:
−15.6
FY25:
−21.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.89
FY22:
−12.2
FY23:
−7.99
FY24:
−14.9
FY25:
−21.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data